Quantification of MUC1 in breast cancer patients. A method comparison study

Autor: G G, Bon, G J, van Kamp, R A, Verstraeten, S, von Mensdorff-Pouilly, J, Hilgers, P, Kenemans

Publikováno v: European journal of obstetrics, gynecology, and reproductive biology. 83(1)

To compare the performance of four serum assays for the quantification of MUC1 in breast cancer patients.A total of 282 serum samples were evaluated with two automated (Boehringer Mannheim Enzymun-Test CA 15-3 and Chiron ACS BR) and two manual assays

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8fca65925a8b8bc7c82681627a990837
https://pubmed.ncbi.nlm.nih.gov/10221613

Multicenter evaluation of the Abbott IMx CA 15-3 assay

Autor: G J, van Kamp, G G, Bon, R A, Verstraeten, D, Lynch, M, Krikau, J, Flückiger, A, Ruibal, P, Kenemans

Publikováno v: Clinical chemistry. 42(1)

We describe a new fully automated procedure for the quantitative measurement of CA 15-3: the microparticle enzyme immunoassay (MEIA) technology developed by Abbott Labs. for the IMx automated immunoassay analyzer. The new IMx CA 15-3 test uses two mo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::65e8da230bdd4c11fd47b540ee9341c7
https://pubmed.ncbi.nlm.nih.gov/8565228

Multicenter technical and clinical evaluation of a fully automated enzyme immunoassay for CA 125

Autor: P, Kenemans, G G, Bon, A C, Kessler, A A, Verstraeten, G J, van Kamp

Publikováno v: Clinical chemistry. 38(8 Pt 1)

The technical performance and clinical usefulness of the newly developed Enzymun-Test CA 125 (Boehringer Mannheim) was evaluated in a multicenter study. Sera tested were obtained from healthy control subjects (n = 1003) and from patients with benign

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4ce7e3839f8c9844e0bff2ea829f6d32
https://pubmed.ncbi.nlm.nih.gov/1643716

Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma.

Autor: Scalera S; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Mazzotta M; Medical Oncology Unit, Sandro Pertini Hospital, Rome, Italy., Calonaci N; Department of Mathematics and Geosciences, University of Trieste, Trieste, Italy., Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Cipriani L; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Bon G; Cellular Network and Molecular Therapeutic Target Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Messina B; Clinical Trial Center, Biostatistics and Bioinformatics Division, IRCCS Regina Elena National Cancer Institute, Roma, Italy., Lamberti G; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Di Federico A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Milite S; Department of Mathematics and Geosciences, University of Trieste, Trieste, Italy., Krasniqi E; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Barba M; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Vici P; UOSD Phase IV Studies, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Vecchione A; Department of Clinical and Molecular Medicine, Pathology Unit, Sant'Andrea Hospital, Sapienza University, Rome, Italy., De Nicola F; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Ciuffreda L; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Goeman F; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Fanciulli M; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Buglioni S; Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Pescarmona E; Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Sharma B; ImmunoProfile, Brigham & Women's Hospital and Dana-Farber Cancer Institute, Boston, USA., Felt KD; ImmunoProfile, Brigham & Women's Hospital and Dana-Farber Cancer Institute, Boston, USA., Lindsay J; Knowledge Systems Group, Dana-Farber Cancer Institute, Boston, USA., Rodig SJ; ImmunoProfile, Brigham & Women's Hospital and Dana-Farber Cancer Institute, Boston, USA; Department of Pathology, Brigham and Women's Hospital, Boston, USA., De Maria R; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Caravagna G; Department of Mathematics and Geosciences, University of Trieste, Trieste, Italy., Cappuzzo F; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Ciliberto G; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Maugeri-Saccà M; Clinical Trial Center, Biostatistics and Bioinformatics Division, IRCCS Regina Elena National Cancer Institute, Roma, Italy; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: marcello.maugerisacca@ifo.it.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Mar; Vol. 34 (3), pp. 275-288. Date of Electronic Publication: 2022 Dec 13.

Monitoring of Dermanyssus gallinae in free-range poultry farms.

Autor: Zenner L; Laboratoire de Biométrie et Biologie Evolutive, Ecole Nationale Vétérinaire de Lyon & Université de Lyon - CNRS UMR 5558, Ecole Nationale Vétérinaire de Lyon, 1 avenue Bourgelat, 69280, Marcy l'Etoile, France. l.zenner@vet-lyon.fr, Bon G, Chauve C, Nemoz C, Lubac S

Publikováno v: Experimental & applied acarology [Exp Appl Acarol] 2009 Jun; Vol. 48 (1-2), pp. 157-66. Date of Electronic Publication: 2009 Feb 28.